Site-specific pegylated linear salmon calcitonin analogues

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9464128
APP PUB NO 20100227815A1
SERIAL NO

12664326

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to site-specific PEGylated linear salmon calcitonin analogs, or pharmaceutically acceptable salts thereof, process for their preparation, pharmaceutical compositions comprising them, and their use for the preparation of a medicament for the treatment or prevention of diseases associated with bone metabolism, e.g., osteoporosis.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY ACADEMY OF MILITARY MEDICAL SCIENCES P L ABEIJING 100850

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Dong, Huajin Beijing, CN 10 36
Gong, Zehui Beijing, CN 4 7
Liang, Yuanjun Beijing, CN 12 46
Liu, Keliang Beijing, CN 7 46
Qie, Jiankun Beijing, CN 2 2
Wang, Ying Beijing, CN 968 7243
Yang, Zhixia Beijing, CN 1 1

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 11, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00